Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Sa, Boerner"'
Autor:
Kc, Bible, Sa, Boerner, Kirkland K, Kl, Anderl, Bartelt D, Pa, Svingen, Tj, Kottke, Yk, Lee, Eckdahl S, Pg, Stalboerger, Rb, Jenkins, Scott Kaufmann
Publikováno v:
Europe PubMed Central
Flavopiridol, the first inhibitor of cyclin-dependent kinases to enter clinical trials, has shown promising antineoplastic activity and is currently undergoing Phase II testing. Little is known about mechanisms of resistance to this agent. In the pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::82fe3da395f0d342a671d01704bcb931
http://europepmc.org/abstract/med/10690552
http://europepmc.org/abstract/med/10690552
Autor:
Maldonado E; University of California, San Francisco, San Francisco, California., Rathmell WK; Vanderbilt University Medical Center, Nashville, Tennessee., Shapiro GI; Dana-Farber Cancer Institute, Boston, Massachusetts., Takebe N; National Cancer Institute, Bethesda, Maryland., Rodon J; Investigational Cancer Therapeutics, MD Anderson Cancer Center, Houston, Texas., Mahalingam D; Northwestern University, Evanston, Illinois., Trikalinos NA; Washington University St. Louis, St. Louis, Missouri., Kalebasty AR; University of California, Irvine, Irvine, California., Parikh M; University of California, Davis, Davis, California., Boerner SA; Yale University, New Haven, Connecticut., Balido C; University of California, San Francisco, San Francisco, California., Krings G; University of California, San Francisco, San Francisco, California., Burns TF; University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania., Bergsland EK; University of California, San Francisco, San Francisco, California., Munster PN; University of California, San Francisco, San Francisco, California., Ashworth A; University of California, San Francisco, San Francisco, California., LoRusso P; Yale University, New Haven, Connecticut., Aggarwal RR; University of California, San Francisco, San Francisco, California.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2024 Jul 01; Vol. 4 (7), pp. 1793-1801.
Autor:
Cecchini M; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Walther Z; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut., Wei W; Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut., Hafez N; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Pilat MJ; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Boerner SA; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Durecki DE; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Eder JP; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut., Schalper KA; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut., Chen AP; Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland., LoRusso P; Department of Internal Medicine (Medical Oncology), Yale University School of Medicine, New Haven, Connecticut.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2023 Jun 26; Vol. 3 (6), pp. 1113-1117. Date of Electronic Publication: 2023 Jun 26 (Print Publication: 2023).
Autor:
LoRusso PM; Yale Cancer Center, Yale University, New Haven, CT, United States of America., Sekulic A; Mayo Clinic, Scottsdale, AZ, United States of America.; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Sosman JA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL, United States of America., Liang WS; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Carpten J; Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America., Craig DW; Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America., Solit DB; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America., Bryce AH; Mayo Clinic, Scottsdale, AZ, United States of America., Kiefer JA; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Aldrich J; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Nasser S; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Halperin R; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Byron SA; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Pilat MJ; Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, United States of America., Boerner SA; Yale Cancer Center, Yale University, New Haven, CT, United States of America., Durecki D; Yale Cancer Center, Yale University, New Haven, CT, United States of America., Hendricks WPD; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Enriquez D; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Izatt T; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Keats J; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Legendre C; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Markovic SN; Mayo Clinic, Rochester, MN, United States of America., Weise A; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI, United States of America., Naveed F; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Schmidt J; Mayo Clinic, Scottsdale, AZ, United States of America., Basu GD; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Sekar S; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Adkins J; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Tassone E; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Sivaprakasam K; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Zismann V; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Calvert VS; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, United States of America., Petricoin EF; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, United States of America., Fecher LA; University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, United States of America., Lao C; University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, United States of America., Eder JP; Yale Cancer Center, Yale University, New Haven, CT, United States of America., Vogelzang NJ; US Oncology, United States of America., Perlmutter J; Gemini Group, Ann Arbor, MI, United States of America., Gorman M; Silver Spring, MD, United States of America., Manica B; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI, United States of America., Fox L; Yale Cancer Center, Yale University, New Haven, CT, United States of America., Schork N; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Zelterman D; Yale Cancer Center, Yale University, New Haven, CT, United States of America., DeVeaux M; Yale Cancer Center, Yale University, New Haven, CT, United States of America.; Regeneron Pharmaceuticals, Tarrytown, NY, United States of America., Joseph RW; Mayo Clinic, Jacksonville, FL, United States of America., Cowey CL; Charles A. Sammons Cancer Center/Baylor University Medical Center, Dallas, TX, United States of America., Trent JM; Translational Genomics Research Institute, Phoenix, AZ, United States of America.
Publikováno v:
PloS one [PLoS One] 2021 Apr 07; Vol. 16 (4), pp. e0248097. Date of Electronic Publication: 2021 Apr 07 (Print Publication: 2021).
Autor:
Goncalves PH; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA., Heilbrun LK; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA., Barrett MT; Mayo Clinic Arizona, Scottsdale, AZ, USA., Kummar S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.; Current address: Stanford University, Palo Alto, CA, USA., Hansen AR; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada., Siu LL; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada., Piekarz RL; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Sukari AW; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA., Chao J; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Pilat MJ; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.; Eugene Applebaum College of Pharmacy and Health Sciences, Physician Assistant Studies, Wayne State University, Detroit, MI, USA., Smith DW; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA., Casetta L; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA., Boerner SA; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.; Current address: Yale Cancer Center, New Haven, CT, USA., Chen A; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA., Lenkiewicz E; Mayo Clinic Arizona, Scottsdale, AZ, USA., Malasi S; Mayo Clinic Arizona, Scottsdale, AZ, USA., LoRusso PM; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.; Current address: Yale Cancer Center, New Haven, CT, USA.
Publikováno v:
Oncotarget [Oncotarget] 2017 May 16; Vol. 8 (20), pp. 32918-32929.
Autor:
LoRusso PM; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. geoffrey_shapiro@dfci.harvard.edu., Li J; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Burger A; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Heilbrun LK; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Sausville EA; University of Maryland Greenebaum Cancer Center, Baltimore, Maryland., Boerner SA; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Smith D; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Pilat MJ; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. Wayne State University, Detroit, Michigan., Zhang J; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Tolaney SM; Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts., Cleary JM; Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts., Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Rubinstein L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Boerner JL; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Bowditch A; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Cai D; Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts., Bell T; Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts., Wolanski A; Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts., Marrero AM; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Zhang Y; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Ji J; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Ferry-Galow K; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Kinders RJ; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Parchment RE; Clinical Pharmacodynamics Biomarker Program, Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland., Shapiro GI; Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 Jul 01; Vol. 22 (13), pp. 3227-37. Date of Electronic Publication: 2016 Feb 03.
Autor:
LoRusso PM; Yale Cancer Center, New Haven, Connecticut. Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan. patricia.lorusso@yale.edu., Boerner SA; Yale Cancer Center, New Haven, Connecticut. Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Pilat MJ; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Forman KM; Yale Cancer Center, New Haven, Connecticut. Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Zuccaro CY; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Kiefer JA; Translational Genomics Research Institute, Phoenix, Arizona., Liang WS; Translational Genomics Research Institute, Phoenix, Arizona., Hunsberger S; Biometrics Research Branch, National Cancer Institute, National Institutes of Health, Rockville, Maryland., Redman BG; University of Michigan Comprehensive Cancer Center (UMCCC), Ann Arbor, Michigan., Markovic SN; Mayo Clinic, Rochester, Minnesota., Sekulic A; Mayo Clinic, Scottsdale, Arizona., Bryce AH; Mayo Clinic, Scottsdale, Arizona., Joseph RW; Mayo Clinic, Jacksonville, Florida., Cowey CL; Charles A. Sammons Cancer Center/Baylor University Medical Center, Dallas, Texas., Fecher LA; University of Michigan Comprehensive Cancer Center (UMCCC), Ann Arbor, Michigan., Sosman JA; Vanderbilt University, Nashville, Tennessee., Chapman PB; Memorial Sloan-Kettering Cancer Center, New York, New York., Schwartz GK; Columbia University, New York, New York., Craig DW; Translational Genomics Research Institute, Phoenix, Arizona., Carpten JD; Translational Genomics Research Institute, Phoenix, Arizona., Trent JM; Translational Genomics Research Institute, Phoenix, Arizona.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2015 Aug; Vol. 14 (8), pp. 1962-71. Date of Electronic Publication: 2015 Jun 10.
Autor:
Boerner JL; Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America., Nechiporchik N; Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America., Mueller KL; Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America., Polin L; Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America., Heilbrun L; Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America., Boerner SA; Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America; Department of Oncology, Yale University, New Haven, Connecticut, United States of America., Zoratti GL; Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America., Stark K; Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America., LoRusso PM; Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America; Department of Oncology, Yale University, New Haven, Connecticut, United States of America., Burger A; Department of Oncology, Wayne State University, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, United States of America.
Publikováno v:
PloS one [PLoS One] 2015 Mar 16; Vol. 10 (3), pp. e0119614. Date of Electronic Publication: 2015 Mar 16 (Print Publication: 2015).
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2013 Jul 03; Vol. 105 (13), pp. 993-4. Date of Electronic Publication: 2013 May 30.
Autor:
Gupta S; Karmanos Cancer Institute, Department of Oncology, Detroit, MI, USA., Hunsberger S, Boerner SA, Rubinstein L, Royds R, Ivy P, LoRusso P
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2012 Dec 19; Vol. 104 (24), pp. 1860-6. Date of Electronic Publication: 2012 Nov 19.